(Q37173751)

18 August 2017

Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening (English)

1 reference

prostate cancer screening

18 August 2017

0 references

1 reference

1 reference

1 reference

U J Lee

1

1 reference

PubMed ID

18504455

18 August 2017

J S Jones

series ordinal

2

1 reference

18 August 2017

27 May 2008

1 reference

Prostate Cancer and Prostatic Diseases

18 August 2017

1 reference

18 August 2017

12

1 reference

18 August 2017

1

1 reference

18 August 2017

52-56

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2008.26

18 August 2017

0 references

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Male breast cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Risk of second primary cancer in men with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Relation between male breast cancer and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Prostate carcinoma metastatic to the male breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Plasma estrogens and androgens in male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

BRCA2 mutation in Icelandic prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Current management of male breast cancer. A review of 104 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Clinical relevance of biologic factors in male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Male patients with diagnoses of both breast cancer and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Linkage to BRCA2 region in hereditary male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Incidence of male breast cancer in Scandinavia, 1943-1982

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Recent cancer trends in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

A 50-year experience of male breast cancer: is outcome changing?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Breast cancer in men: risk factors with hormonal implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Hormones in male breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

BRCA2 germ-line mutations in Spanish male breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Carcinoma of the male breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Second primary cancers in men with prostate cancer: an increased risk of male breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.26

31 March 2020

Identifiers

DOI

10.1038/PCAN.2008.26

1 reference

18 August 2017

1 reference

PubMed ID

18504455